Profil
Nicola Cadei is currently the General Manager & Director at Pharmatex Italia SRL since 2016.
He is also a Member-Supervisory Board at BIOTON SA since 2019.
Previously, he worked as the Director-Commercial Operations at AstraZeneca SpA from 2006 to 2008 and as the Chief Operating Officer at Mipharm SpA from 2010 to 2015.
Mr. Cadei completed his undergraduate degree at the University of Milan in 1990.
Aktiva positioner av Nicola Cadei
| Företag | Position | Start |
|---|---|---|
| BIOTON S.A. | Direktör/Styrelseledamot | 2022-07-12 |
Pharmatex Italia SRL
Pharmatex Italia SRL Pharmaceuticals: OtherHealth Technology Engages in pharmaceuticals production | Verkställande Direktör | 2016-01-01 |
Tidigare kända positioner av Nicola Cadei
| Företag | Position | Slut |
|---|---|---|
Mipharm SpA
Mipharm SpA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and generic drugs | Verksamhetschef | 2015-01-01 |
AstraZeneca SpA
AstraZeneca SpA Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Comptroller/Controller/Revisor | 1995-01-01 |
Nicola Cadeis utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
BIOTON SA
BIOTON SA Pharmaceuticals: MajorHealth Technology Manufactures medicines and pharmaceutical preparations and substances | Health Technology |
University of Milan
University of Milan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmatex Italia SRL
Pharmatex Italia SRL Pharmaceuticals: OtherHealth Technology Engages in pharmaceuticals production | Health Technology |
AstraZeneca SpA
AstraZeneca SpA Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Mipharm SpA
Mipharm SpA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and generic drugs | Health Technology |
















